Evidence map›Paper›PMID 42058719›Full record

ArticleMethodsX2026

Detecting neurobiological markers in treatment response to prolonged exposure therapy for PTSD: An RCT using functional near-infrared spectroscopy.

Duane D Booysen, Sizwe Zondo

Abstract read
In one paragraph

Article in MethodsX, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Duane D BooysenRhodes University, Department of Psychology, Faculty of Humanities, 1 University Road, Makhanda, 6139, South Africa.
Sizwe ZondoRhodes University, Department of Psychology, Faculty of Humanities, 1 University Road, Makhanda, 6139, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trauma exposure and post-traumatic stress disorder (PTSD) are a global public health concern, especially in low and middle-income countries (LMICs). University students are a unique population that has been found to have increased levels of trauma exposure and PTSD, yet limited clinical outcome and neurobiological data exist, especially in LMICs, on treatment responses to evidence-based trauma-focused treatments for PTSD among university students in LMICs. The development and integration of neuroimaging tools in psychotherapy enable more robust integration of data from clinical psychology and neuroscience. Our protocol is the first to use functional Near-infrared spectroscopy (fNIRS) to investigate the treatment response of a first-line trauma-focused cognitive behavioural therapy, namely, prolonged exposure therapy, for the treatment of PTSD. Using a pilot randomised controlled trial, university students diagnosed with PTSD will be assessed using clinical outcome measures and fNIRS to ascertain prefrontal cortical increases and decreases in persons diagnosed with PTSD. Participants will be randomised to either the experimental condition (PE) or a comparative control condition (supportive counselling). Participants will be assessed at baseline, post-intervention, and at 12 and 24-week follow-ups using the same measures and imaging.•Recruit and assess university students using standard clinical measures and fNIRS for PTSD.•Assign enrolled students to either PE (experimental condition) or supportive counselling (control condition) for a minimum of 8 sessions.•Assess students at the end of treatment and at 12 and 24-week follow-ups using the same clinical measures and fNIRS for any changes in PTSD.

Indexed as

Functional near-infrared spectroscopyProlonged exposure therapyPTSDRandomized clinical trial

Identifiers

PMID42058719
PMCPMC13123371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.